KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Boston Scientific (BSX) Other Operating Expenses (2016 - 2025)

Boston Scientific (BSX) has disclosed Other Operating Expenses for 16 consecutive years, with $342.0 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses fell 5.26% to $342.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 billion through Dec 2025, down 14.05% year-over-year, with the annual reading at $1.1 billion for FY2025, N/A changed from the prior year.
  • Other Operating Expenses hit $342.0 million in Q4 2025 for Boston Scientific, up from $247.0 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $500.0 million in Q2 2024 to a low of -$22.0 million in Q4 2022.
  • Historically, Other Operating Expenses has averaged $203.3 million across 5 years, with a median of $238.0 million in 2025.
  • Biggest five-year swings in Other Operating Expenses: plummeted 173.33% in 2022 and later soared 1168.18% in 2023.
  • Year by year, Other Operating Expenses stood at $30.0 million in 2021, then tumbled by 173.33% to -$22.0 million in 2022, then skyrocketed by 1168.18% to $235.0 million in 2023, then soared by 53.62% to $361.0 million in 2024, then decreased by 5.26% to $342.0 million in 2025.
  • Business Quant data shows Other Operating Expenses for BSX at $342.0 million in Q4 2025, $247.0 million in Q3 2025, and $280.0 million in Q2 2025.